News
2d
Pharmaceutical Technology on MSNBiocon’s Denosumab biosimilars gain EU marketing authorisationClinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.
2d
ET Now on MSNBiocon, DMart Stocks | Why Rudramurthy BV Is Bullish On The Stocks | Stock Market Views | ET NowCA Rudramurthy BV is bullish on Biocon and DMart, citing strong technical setups and sectoral promise. Biocon’s breakout from ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...
Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...
Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...
Karnataka CM Siddaramaiah and Biocon chief Kiran Mazumdar-Shaw have been up in arms against each other over the heated debate ...
Biocon founder Kiran Mazumdar-Shaw refutes Karnataka CM's claim linking Covid-19 vaccines to heart attack deaths in Hassan ...
Biocon chief Kiran Mazumdar-Shaw has pushed back against Karnataka Chief Minister Siddaramaiah's recent claim that COVID-19 ...
CM Siddaramaiah responds to Biocon chief's vaccine remarks after Hassan deaths; Kiran Mazumdar Shaw calls for truce.
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results